Stockhub

Avacta Group Plc: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

3 June 2023

15 August 2022

  • curprev 08:5508:55, 15 August 2022‎ Paris talk contribs‎ 1,338 bytes +1,338‎ Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Avacta Group Plc, a clinical stage biopharmaceutical company, develops cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms in the United Kingdom, North America, South Korea, and rest of Asia and Europe. It operates through Diagnostics and Therapeutics segments. The company develops custom Affimer proteins for customer products and in-house diagnostic assays. It also develops AffiDX SAR..." Tag: Visual edit: Switched
Retrieved from ‘https://stockhub.co/research/Avacta_Group_Plc’